The pharmacological inhibition of the mammalian target of rapamycin (mTOR) by rapamycin induces the mutant htt clearance and decreases the level of soluble proteins and aggregates and cell death in the in vitro HD model [159]. The gene discussed is MTOR; the disease is Huntington disease.